Focus marzo-aprile 2016
Italiano
The presence of glass particulate matter could block drug administration, delaying therapy, and may also result in local inflammation, mechanical disruption of tissue, or cause an immune response.
The presence of air in dialysis fluid may lead to improper blood filtration, causing serious adverse health consequences, including death.
Degradation could lead to loss of device function, separation of a device segment leading to medical intervention, or complications resulting from a separated segment.
Compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of
aripiprazole, and may result in harm to the patient and others if not recognized.
During transition from the name Brintellix to Trintellix, prescribers can reduce the risk of name confusion by including the generic name of the medication they are ordering, in addition to the brand name and indication for use.
Undeclared sibutramine or sildenafil poses a threat to consumers.
L'Agenzia Italiana del Farmaco rende disponibile nuove e importanti informazioni sui medicinali a base di canagliflozin -
INVOKANA (canagliflozin), VOKANAMET (canagliflozin/metformina) - e il
rischio di amputazione a livello degli arti inferiori (soprattutto a
carico delle dita del piede).
L'Agenzia europea dei medicinali (EMA) ha concluso la rivalutazione dei corticosteroidi inalatori per il
trattamento della malattia polmonare cronica ostruttiva.
L'Agenzia europea dei medicinali (EMA) ha avviato una revisione dei medicinali per i quali sono stati condotti studi presso il centro di ricerche privato Semler Ltd, sito a Bangalore (India).
80.211.154.110